Mitoxantrone (Teva®)

Common name: Mitoxantrone
Brand name: Teva®
 

What is Mitoxantrone?

Mitoxantrone is a chemotherapy drug used to treat advanced prostate cancer by interfering with the growth and reproduction of cancer cells. This therapy is used in combination with corticosteroids, such as prednisone or prednisolone.


How is Mitoxantrone administered?

Mitoxantrone is administered by injection.
 

What are possible side effects of this treatment?

Everyone responds differently to chemotherapy – some experience many side effects while others experience very few. Below are some side effects experienced by those who received mitoxantrone. Tell your health care team about side-effects you are experiencing so they know how best to help you manage them.

 
•    Bleeding / bruising
•    Diarrhea
•    Fatigue
•    Hair loss
•    Infection
•    Liver problems
•    Mouth sores
•    Nausea / vomiting
•    Pain, burning, redness, swelling at injection site
 
 

Is Mitoxantrone covered in my province or territory?

Provincial Coverage: Unknown    
    
Last Reviewed: July 2017

Help us take the first steps toward prevention. Donate Now




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.
More

Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body.
More

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More


Click here for news archive